Sale!

Episodic Ataxia Type 1 Hotspot Test

Original price was: $376.Current price is: $288.

-23%

The Episodic Ataxia Type 1 Hotspot Test is a specialized genetic analysis that identifies mutations in the KCNA1 gene responsible for episodic ataxia type 1, a rare neurological disorder characterized by recurrent episodes of poor coordination and balance. This comprehensive test provides crucial diagnostic information for individuals experiencing unexplained episodes of ataxia, helping to confirm diagnosis and guide appropriate treatment strategies. The test utilizes advanced PCR and sequencing methodologies to ensure accurate detection of specific genetic variations. At just $288 USD, this affordable genetic screening offers peace of mind and valuable insights for patients and their families dealing with neurological symptoms. Early genetic diagnosis can significantly impact treatment planning and family counseling decisions.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Episodic Ataxia Type 1 Hotspot Test

Understanding Episodic Ataxia Type 1

Episodic Ataxia Type 1 (EA1) is a rare inherited neurological disorder characterized by recurrent episodes of poor coordination and balance (ataxia) that typically begin in childhood. These episodes can last from seconds to minutes and are often triggered by physical exertion, emotional stress, or sudden movements. The condition results from mutations in the KCNA1 gene, which encodes a potassium channel protein essential for proper nerve cell function.

What This Test Measures

The Episodic Ataxia Type 1 Hotspot Test specifically analyzes the KCNA1 gene for known pathogenic mutations associated with this neurological condition. Using advanced molecular diagnostic techniques including PCR and sequencing, our laboratory examines critical regions of the gene where mutations most commonly occur. This targeted approach ensures high accuracy in detecting the genetic variations responsible for EA1 symptoms.

Key Test Components:

  • Comprehensive analysis of KCNA1 gene hotspots
  • Detection of point mutations and small deletions/insertions
  • Identification of known pathogenic variants
  • High-resolution sequencing for accurate results

Who Should Consider This Test?

This genetic test is recommended for individuals experiencing symptoms suggestive of episodic ataxia or those with a family history of similar neurological conditions. Key indications include:

Symptoms and Clinical Presentations:

  • Recurrent episodes of unsteadiness or loss of balance
  • Brief attacks of coordination difficulties lasting seconds to minutes
  • Muscle twitching or myokymia between ataxic episodes
  • Symptoms triggered by exercise, stress, or sudden movements
  • Onset of symptoms in childhood or early adolescence
  • Family history of similar neurological symptoms
  • Unexplained episodes of dizziness or vertigo

Benefits of Genetic Testing

Undergoing the Episodic Ataxia Type 1 Hotspot Test provides numerous advantages for patients and their families:

Diagnostic Clarity:

  • Confirm or rule out EA1 diagnosis with genetic evidence
  • Differentiate from other movement disorders with similar symptoms
  • Provide definitive answers for unexplained neurological symptoms

Treatment Guidance:

  • Inform appropriate medication choices (acetazolamide response)
  • Guide lifestyle modifications to avoid triggers
  • Support comprehensive neurological management

Family Planning:

  • Understand inheritance patterns (autosomal dominant)
  • Provide genetic counseling for family members
  • Enable informed reproductive decisions

Understanding Your Test Results

Our comprehensive genetic counseling support helps you interpret your results effectively:

Positive Result:

A positive result indicates the presence of a pathogenic mutation in the KCNA1 gene, confirming the diagnosis of Episodic Ataxia Type 1. This information allows for targeted treatment approaches and provides clarity about the condition’s inheritance pattern.

Negative Result:

A negative result suggests that no known pathogenic mutations were detected in the analyzed KCNA1 gene regions. However, this does not completely rule out EA1, as rare mutations outside the tested hotspots may exist. Further evaluation may be recommended.

Variant of Uncertain Significance:

In some cases, genetic changes of unknown clinical significance may be identified. Our genetic counselors will provide guidance on the implications and recommend appropriate follow-up.

Test Pricing and Details

Test Component Price (USD)
Episodic Ataxia Type 1 Hotspot Test $376
Discount Price $288

Turnaround Time:

Sample received by Monday 11:00 AM | Report delivered by Friday

Sample Requirements:

  • 4 mL (2 mL minimum) whole blood from 1 Lavender Top (EDTA) tube
  • Ship refrigerated – DO NOT FREEZE
  • Completed Genomics Clinical Information Requisition Form (Form 20) mandatory

Nationwide Accessibility

We have diagnostic centers conveniently located across the United States, serving major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, and San Jose. Our network ensures accessible genetic testing services regardless of your location.

Take the Next Step Toward Diagnosis

If you or a family member experiences symptoms suggestive of episodic ataxia, don’t wait to get answers. Our specialized neurological genetics testing provides the clarity needed for proper diagnosis and management. Contact our genetic counseling team to discuss your symptoms and determine if this test is right for you.

Book your Episodic Ataxia Type 1 Hotspot Test today by calling our dedicated genetics hotline at +1(267) 388-9828 or schedule your appointment online. Take control of your neurological health with definitive genetic answers.